Sanya A. Springfield will join the Office of the NCI Director as an acting deputy director, charged with broadening and strengthening cancer health equity and inclusion programs, effective in the coming weeks.
Judith O. Hopkins, of Southeast Clinical Oncology, a group of community physicians operating in the southeastern United States, won the 2024 Harry Hynes award, which is given annually to the PI who reflects the outstanding contribution to clinical trials and community research.
Drs. Melissa Pilewskie (left) and Monika Burness, co-leads of the Weiser Family Center for Breast CancerPhoto credit: Michigan MedicineThe Weiser Charitable Foundation donated $25 million to support the establishment the Weiser Family Center for Breast Cancer at the University of Michigan Health Rogel Cancer Center.
Cure4Cancer and the Bloomberg New Economy Cancer Coalition published its latest study in Cancer Discovery on the global access and participation in oncology clinical trials, a first of its kind analysis through a multi-stakeholder collaboration.
Sen. Jeanne Shaheen (D-NH) and Sen. Tammy Baldwin (D-WI) plan to introduce the Health Care Affordability Act of 2024, which would make permanent the Affordable Care Act enhanced tax credits that help make health insurance coverage affordable for an estimated 20 million people.
The University of Texas MD Anderson Cancer Center announced its first-ever academic journal, Advances in Cancer Education & Quality Improvement. The journal will publish research, training program summaries, and quality improvement interventions for the oncology provider community.
Anthony Stack has joined Fox Chase Cancer Center as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.
Hilario Yankey joins Fox Chase Cancer Center as an assistant professor in the Department of Radiation Oncology.
Roger Lo, professor of medicine, dermatology, and molecular and medical pharmacology and investigator at the UCLA Health Jonsson Comprehensive Cancer Center, was awarded a $2 million grant from NIH to investigate innovative strategies to prevent drug resistance in melanoma treatment and improve the effectiveness of MAPK inhibitors, a common treatment for patients with melanomas that carry the BRAFV600 mutation.
Tampa General Hospital and Mass General Brigham announced a strengthening of their affiliation with the development of new programs and services, including a bone marrow transplant program and CAR T therapy program, at TGH.
